Advancis Surgical is founded on the principles of enterprise and innovation. We pride ourselves on our ability to develop original ideas into medical products, which bring real benefits to both patients and health care professionals.

Advancis Surgical is a new trading division of Brightwake Ltd – building on the company’s medical development expertise and the sales success of its existing trading arm, Advancis Medical.

We are pleased to launch our first product – the ground-breaking blood recycling system, Hemosep.Cell Salvage device

The Hemosep cell salvage device is designed to recover blood spilled during open-heart and orthopaedic surgery to enable the salvage of blood, providing a concentration of all cell species for transfusion back to the patient.

Developed with the support of universities in the UK and abroad, Hemosep is already generating interest worldwide. It offers exciting new opportunities for health services to improve patient outcomes and reduce costs. Read more about the benefits of Hemosep.


Hemosep is the result of a partnership with Professor Terence Gourlay at the University of Strathclyde, with full trials taking place at the world-leading University of Kirikkale University Hospital in Ankara, Turkey.

Professor Terence Gourlay, says: “The introduction of Hemosep to the medical device field will make a significant difference to people’s lives and greatly reduce the cost and risks associated with blood transfusions. The technology has distinct advantages over traditional techniques which are not only costly but technically challenging and involve the use of a complex centrifuge and pumping apparatus by specialist technicians.”

Professor Serdar Gunaydin says: “The Hemosep technology has produced impressive results, it is the easiest method we have ever used. There is no interference with the on-going operation and product is ready following a very short processing time. We believe this new technology will be one of the essential components of routine heart surgery in the near future.”

Stephen Cotton, Brightwake’s Director of Research and Development, said: “We’re delighted to be able to make this announcement, which comes after considerable shared effort to develop this exciting product. We hope that this success will be the first of many through our collaboration with the University of Strathclyde.”